Inhibition of Ubiquitin Ligase F-box and WD Repeat Domain-containing 7α (Fbw7α) Causes Hepatosteatosis through Kruppel-like Factor 5 (KLF5)/Peroxisome Proliferator-activated Receptor γ2 (PPARγ2) Pathway but Not SREBP-1c Protein in Mice
Inhibition of Ubiquitin Ligase F-box and WD Repeat Domain-containing 7α (Fbw7α) Causes Hepatosteatosis through Kruppel-like Factor 5 (KLF5)/Peroxisome Proliferator-activated Receptor γ2 (PPARγ2) Pathway but Not SREBP-1c Protein in Mice
复制标题
DOI:
10.1074/jbc.m111.235283
复制
发表时间:
2011-11-25
影响因子:
4.8
通讯作者:
Shimano, Hitoshi
中科院分区:
文献类型:
--
作者:
Kumadaki, Shin;Karasawa, Tadayoshi;Shimano, Hitoshi
F-box and WD repeat domain-containing 7 alpha (Ebw7 alpha) is the substrate recognition component of a ubiquitin ligase that controls the degradation of factors involved in cellular growth, including c-Myc, cyclin E, and c-Jun. In addition, Fbw7 alpha degrades the nuclear form of sterol regulatory element-binding protein (SREBP)-1a, a global regulator of lipid synthesis, particularly during mitosis in cultured cells. This study investigated the in vivo role of Ebw7 alpha in hepatic lipid metabolism. siRNA knockdown of Ebw7 alpha in mice caused marked hepatosteatosis with the accumulation of triglycerides. However, inhibition of Ebw7 alpha did not change the level of nuclear SREBP-1 protein or the expression of genes involved in fatty acid synthesis and oxidation. In vivo experiments on the gain and loss of Fbw7 alpha function indicated that Fbw7 alpha regulated the expression of peroxisome proliferator-activated receptor (PPAR) gamma 2 and its target genes involved in fatty acid uptake and triglyceride synthesis. These genes included fatty acid transporter Cd36, diacylglycerol acyltransferase 1 (Dgatl), and fat-specific protein 27 (Cidec). The regulation of PPAR gamma 2 by Fbw7 alpha was mediated, at least in part, by the direct degradation of the Krtippel-like factor 5 (KI.F5) protein, upstream of PPAR gamma 2 expression. Hepatic Fbw7 alpha contributes to normal fatty acid and triglyceride metabolism, functions that represent novel aspects of this cell growth regulator.